Back to Search
WALTER BERGER, PHD, MD
PHD, MD
Psychiatry Physician
NPI: 1306920574Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
47619(MN)
Research & Publications (20)
Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis.
PMID 19220164·Expert Opin Drug Metab Toxicol·2009
6-review
Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease.
PMID 18023995·Respir Med·2008
6-review
Novel method for recolonoscopy after percutaneous cecostomy.
PMID 18243187·Gastrointest Endosc·2008
5-case
Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.
PMID 17970670·Expert Opin Drug Deliv·2007
6-review
Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.
PMID 17394438·Int J Clin Pract·2007
6-review
Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
PMID 17165278·Ann Allergy Asthma Immunol·2006
4-observational
Ciclesonide: a closer look at its systemic and oropharyngeal safety profile.
PMID 18690937·Curr Drug Saf·2006
6-review
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
PMID 16846555·Curr Med Res Opin·2006
4-observational
Asthma and COPD: definitions, epidemiology, and treatment guidelines.
PMID 19667710·Postgrad Med·2005
6-review
The safety and efficacy of desloratadine for the management of allergic disease.
PMID 16329713·Drug Saf·2005
6-review
Paediatric pulmonary drug delivery: considerations in asthma treatment.
PMID 16296802·Expert Opin Drug Deliv·2005
6-review
Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis.
PMID 16278257·Ann Pharmacother·2005
2-rct
Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze.
PMID 15644830·J Pediatr·2005
3-trial
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes.
PMID 15609762·Ann Allergy Asthma Immunol·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2101 ELM ST N
FARGO, ND 58102 - Phone
- (701) 232-3241
Quick Facts
- NPI
- 1306920574
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile